137 related articles for article (PubMed ID: 2938250)
1. SA 96 (N-(2-mercapto-2-methylpropanoyl)-L-cysteine) in rheumatoid arthritis.
Ishikawa K; Sakaguchi M
Scand J Rheumatol; 1986; 15(1):85-90. PubMed ID: 2938250
[TBL] [Abstract][Full Text] [Related]
2. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
[TBL] [Abstract][Full Text] [Related]
3. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
[TBL] [Abstract][Full Text] [Related]
4. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation.
Manthorpe R; Hørbov S; Sylvest J; Vinterberg H
Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505
[TBL] [Abstract][Full Text] [Related]
5. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
Stein HB; Ruedy J; Atkins CJ; Offer RC
Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
[TBL] [Abstract][Full Text] [Related]
6. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
Girgis L; Conaghan PG; Brooks P
Curr Opin Rheumatol; 1994 May; 6(3):252-61. PubMed ID: 7914739
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of penicillamine in rheumatoid arthritis.
Rothermich NO; Thomas MH; Phillips VK; Bergen W
Arthritis Rheum; 1981 Dec; 24(12):1473-8. PubMed ID: 7034736
[TBL] [Abstract][Full Text] [Related]
8. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
[TBL] [Abstract][Full Text] [Related]
9. Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.
Berry H; Fernandes L; Ford-Hutchinson AW; Evans SJ; Hamilton EB
Ann Rheum Dis; 1978 Feb; 37(1):93-7. PubMed ID: 24426
[TBL] [Abstract][Full Text] [Related]
10. [A trial of comparative effects of gold salts and D-penicillamine in rheumatoid arthritis].
Nezić-Ivković J; Dürrigl T
Reumatizam; 1978; 25(3):75-8. PubMed ID: 353935
[No Abstract] [Full Text] [Related]
11. A retrospective analysis of drug therapy in patients with rheumatoid arthritis.
Bosmanský K; Trnavský K
Z Rheumatol; 1983; 42(2):86-9. PubMed ID: 6880407
[TBL] [Abstract][Full Text] [Related]
12. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
Warnatz H; Scheiffarth F; Gutmann W
Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
[TBL] [Abstract][Full Text] [Related]
13. A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis.
Mbuyi-Muamba JM; Dequeker J
Clin Rheumatol; 1983 Dec; 2(4):369-74. PubMed ID: 6678197
[TBL] [Abstract][Full Text] [Related]
14. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
Tsvetkova ES
Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
[TBL] [Abstract][Full Text] [Related]
15. Gold vs D-penicillamine double blind study and followup.
Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
[TBL] [Abstract][Full Text] [Related]
16. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
Kim HA; Song YW
Rheumatol Int; 1997; 17(1):5-9. PubMed ID: 9194208
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)].
Fujimura H; Hiramatsu Y; Tamura Y; Yanagihara M; Koda A; Nagai H; Uda K; Iso T; Yamauchi H
Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):117-29. PubMed ID: 6249702
[TBL] [Abstract][Full Text] [Related]
18. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
Hochberg MC
Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
[TBL] [Abstract][Full Text] [Related]
19. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.
Ward JR
Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055
[TBL] [Abstract][Full Text] [Related]
20. Observations on in vivo skin elasticity and skin thickness of patients with rheumatoid arthritis treated with D-penicillamine and gold salts.
Harvey W; Henderson DR; Grahame R
Postgrad Med J; 1974 Aug; 50 Suppl 2():33-6. PubMed ID: 4467174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
